Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 14, 2019
Total Value: $1.003B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,046,832 | $241M | 24.0% | $26.35 | — | ADR | 04351P101 |
| CRNX | Crinetics Pharmaceuticals Inc | 3,375,169 | $76.82M | 7.7% | $29.69 | -17.2% | Common | 22663K107 |
| CDXS | Codexis, Inc | 2,618,951 | $53.77M | 5.4% | $3.85 | +403.9% | Common | 192005106 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,328,475 | $42.73M | 4.3% | $8.05 | +105.0% | Common | 04280A100 |
| KALV | KalVista Pharmaceuticals Inc. | 1,359,149 | $38.9M | 3.9% | $12.10 | +79.1% | Common | 483497103 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 3.8% | $7.22 | -9.5% | SHS | P8696W104 |
| INSM | Insmed Inc | 1,170,290 | $34.02M | 3.4% | $25.92 | 0.0% | Common Par | 457669307 |
| — | Kadmon Holdings Inc | 12,606,605 | $33.28M | 3.3% | $5.06 | — | Common | 48283N106 |
| — | Homology Medicines, Inc. | 1,159,742 | $32.16M | 3.2% | $19.00 | — | Common | 438083107 |
| — | Menlo Therapeutics Inc. | 4,011,236 | $31.49M | 3.1% | $37.58 | — | Common | 586858102 |
| — | Tricida, Inc. | 781,185 | $29.53M | 2.9% | $29.90 | — | Common | 89610F101 |
| — | Cymabay Therapeutics Inc | 2,056,000 | $27.3M | 2.7% | $13.17 | — | Common | 23257D103 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 504,980 | $25.99M | 2.6% | $36.97 | — | Common | G11196105 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $25.04M | 2.5% | $16.42 | — | Common | 28249U105 |
| — | Mirati Therapeutics Inc. | 251,107 | $18.41M | 1.8% | $42.42 | — | Common | 60468T105 |
| — | MEI Pharma Inc | 5,778,106 | $17.74M | 1.8% | $3.94 | — | Common | 55279B202 |
| — | Kiniksa Pharmaceuticals | 843,478 | $15.23M | 1.5% | $18.60 | — | Common | G5269C101 |
| IOVA | Iovance Biotherapeutics, Inc. | 1,600,000 | $15.22M | 1.5% | $9.64 | +0.7% | Common | 462260100 |
| XENE | Xenon Pharmaceuticals Inc | 1,405,476 | $14.28M | 1.4% | $11.59 | -26.8% | Common | 98420N105 |
| — | Acer Therapeutics Inc | 579,051 | $14.07M | 1.4% | $30.59 | — | Common | 00444P108 |
| — | Obseva SA | 937,147 | $11.99M | 1.2% | $15.18 | — | Common | H5861P103 |
| — | Amyris, Inc | 5,575,785 | $11.65M | 1.2% | $5.54 | — | Common | 03236M200 |
| QURE | Uniqure NV | 180,336 | $10.76M | 1.1% | $44.67 | 0.0% | Common | N90064101 |
| — | Nabriva Therapeutics AG | 4,403,687 | $10.74M | 1.1% | $6.08 | — | SHS | G63637105 |
| — | Zymeworks Inc | 620,134 | $10.03M | 1.0% | $14.78 | — | Common | 98985W102 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $9.867M | 1.0% | $19.11 | -65.3% | Common | 00461U105 |
| — | Verona Pharma PLC | 1,492,951 | $9.704M | 1.0% | $13.61 | — | ADS | 925050106 |
| — | Dermira Inc | 700,000 | $9.485M | 0.9% | $13.55 | — | Common | 24983L104 |
| — | Soleno Therapeutics, Inc. | 4,359,683 | $8.981M | 0.9% | $1.84 | — | Common | 834203200 |
| — | Kala Pharmaceuticals, Inc. | 1,043,020 | $8.626M | 0.9% | $22.84 | — | Common | 483119103 |
| — | Orchard Therapeutics plc | 481,609 | $8.611M | 0.9% | $15.73 | — | ADS | 68570P101 |
| — | Galmed Pharmaceuticals Ltd | 971,337 | $7.936M | 0.8% | $11.38 | — | SHS | M47238106 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,213,290 | $7.886M | 0.8% | $5.62 | +18.1% | Common | 05156V102 |
| APLS | Apellis Pharmaceuticals, Inc. | 383,538 | $7.479M | 0.7% | $14.72 | +6.8% | Common | 03753U106 |
| — | Matinas Biopharma Hldgs Inc | 6,818,181 | $7.432M | 0.7% | $1.09 | — | Common | 576810105 |
| — | Zogenix Inc | 105,000 | $5.776M | 0.6% | $40.05 | — | Common | 98978L204 |
| — | Precision Biosciences Inc | 280,511 | $5.035M | 0.5% | $17.95 | — | Common | 74019P108 |
| — | Genocea Biosciences Inc | 7,811,206 | $4.609M | 0.5% | $1.05 | — | Common | 372427104 |
| — | Strongbridge Biopharma plc | 914,062 | $4.552M | 0.5% | $4.98 | — | SHS USD | G85347105 |
| — | Sierra Oncology, Inc | 2,438,270 | $4.169M | 0.4% | $1.55 | — | Common | 82640U107 |
| — | Agile Therapeutics, Inc. | 1,513,975 | $2.286M | 0.2% | $6.21 | — | Common | 00847L100 |
| ZLAB | Zai Lab Limited | 71,595 | $2.113M | 0.2% | $27.00 | — | ADR | 98887Q104 |
| — | DBV Technologies S.A. | 269,995 | $2.082M | 0.2% | $6.42 | — | ADR | 23306J101 |
| — | Trevena, Inc. | 1,233,677 | $1.925M | 0.2% | $7.67 | — | Common | 89532E109 |
| — | BioPharmX Corporation | 16,128,515 | $1.419M | 0.1% | $0.36 | — | Common | 09072X101 |
| — | Selecta Biosciences Inc | 546,054 | $1.289M | 0.1% | $19.86 | — | Common | 816212104 |
| — | Akari Therapeutics Plc | 345,850 | $1.238M | 0.1% | $14.00 | — | ADR | 00972G108 |
| — | Sunesis Pharmaceuticals, Inc. | 99,441 | $121K | 0.0% | $3.62 | — | Common Par | 867328700 |
| — | Soleno Therapeutics, Inc. - Warrant | 188,772 | $28,000 | 0.0% | $0.14 | — | Warrant | 834203135 |